SCHEMBL5482060

SCHEMBL5482060

CCc1cc(C(N)=O)c(OC)c(OC)c1CC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCOA1 Q15788 1/20 0.38
NCOA3 Q9Y6Q9 1/20 0.38
ALDH1A1 P00352 4/20 0.37
KDM4E B2RXH2 3/20 0.37
HTT P42858 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
MAPK10 P53779 1/20 0.37
IKBKB O14920 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
TSHR P16473 2/20 0.36
APOBEC3A P31941 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36
NNMT P40261 1/20 0.36
BPTF Q12830 1/20 0.35
POLB P06746 2/20 0.35
MAPT P10636 1/20 0.35
RAB9A P51151 1/20 0.35
NPC1 O15118 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28393333 0.83 ALDH1A1 (0.37) NCOA1NCOA3ALDH1A1KDM4EHTT
SCHEMBL13729466 0.80 SMN1; SMN2 (0.38) NCOA1NCOA3ALDH1A1KDM4EHTT
SCHEMBL7594740 0.79 NNMT (0.40) NCOA1NCOA3ALDH1A1KDM4EHTT
SCHEMBL27734973 0.79 NCOA1 (0.35) NCOA1NCOA3ALDH1A1KDM4EHTT
SCHEMBL9755787 0.78 KDM4E (0.42) NCOA1NCOA3ALDH1A1KDM4EHTT
SCHEMBL28975003 0.77 KDM4E (0.41) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL6588836 0.76 SMN1; SMN2 (0.38) NCOA1NCOA3ALDH1A1KDM4EHTT
SCHEMBL7414268 0.76 KDM4E (0.34) NCOA1NCOA3ALDH1A1KDM4EHTT
SCHEMBL28925024 0.76 NNMT (0.40) NCOA1NCOA3ALDH1A1KDM4EHTT
Hydrochloric Acid SCHEMBL28553424 0.75 NNMT (0.39) NCOA1NCOA3ALDH1A1KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070254906-A1 Method of Administration of Dopamine Receptor Agonists DARPHARMA, INC. (US) 2007-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254906-A1 Method of Administration of Dopamine Receptor Agonists ADRA1D, DRD2, CHRM3 NCOA1 3320/4885NCOA3 2801/4885ALDH1A1 2158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.